Vlieg-Boerstra B J, Duiverman E J, van der Heide S, Bijleveld C M A, Kukler J, Dubois A E J
Department of Paediatrics, Division of Paediatric Pulmonology and Paediatric Allergy, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Clin Exp Allergy. 2008 Dec;38(12):1935-42. doi: 10.1111/j.1365-2222.2008.03088.x. Epub 2008 Sep 3.
Data on the frequency of resolution of anaphylaxis to foods are not available, but such resolution is generally assumed to be rare.
To determine whether the frequency of negative challenge tests in children with a history of anaphylaxis to foods is frequent enough to warrant challenge testing to re-evaluate the diagnosis of anaphylaxis, and to document the safety of this procedure.
All children (n=441) who underwent a double-blind, placebo-controlled food challenge (DBPCFC) between January 2003 and March 2007 were screened for symptoms of anaphylaxis to food by history. Anaphylaxis was defined as symptoms and signs of cardiovascular instability, occurring within 2 h after ingestion of the suspected food.
Twenty-one children were enrolled (median age 6.1 years, range 0.8-14.4). The median time interval between the most recent anaphylactic reaction and the DBPCFC was 4.25 years, range 0.3-12.8. Twenty-one DBPCFCs were performed in 21 children. Eighteen of 21 children were sensitized to the food in question. Six DBPCFCs were negative (29%): three for cows milk, one for egg, one for peanut, and one for wheat. In the positive DBPCFCs, no severe reactions occurred, and epinephrine administration was not required.
This is the first study using DBPCFCs in a consecutive series of children with a history of anaphylaxis to foods, and no indications in dietary history that the food allergy had been resolved. Our study shows that in such children having specific IgE levels below established cut-off levels reported in other studies predicting positive challenge outcomes, re-evaluation of clinical reactivity to food by DBPCFC should be considered, even when there are no indications in history that anaphylaxis has resolved. DBPCFCs can be performed safely in these children, although there is a potential risk for severe reactions.
关于食物过敏反应消退频率的数据尚无可用资料,但一般认为这种消退情况较为罕见。
确定有食物过敏反应病史的儿童中阴性激发试验的频率是否足够高,以证明进行激发试验来重新评估过敏反应诊断的合理性,并记录该操作的安全性。
对2003年1月至2007年3月间接受双盲、安慰剂对照食物激发试验(DBPCFC)的所有儿童(n = 441)进行食物过敏反应症状的病史筛查。过敏反应定义为摄入可疑食物后2小时内出现的心血管不稳定的症状和体征。
纳入21名儿童(中位年龄6.1岁,范围0.8 - 14.4岁)。最近一次过敏反应与DBPCFC之间的中位时间间隔为4.25年,范围0.3 - 12.8年。对21名儿童进行了21次DBPCFC。21名儿童中有18名对所涉食物敏感。6次DBPCFC为阴性(29%):3次针对牛奶,1次针对鸡蛋,1次针对花生,1次针对小麦。在阳性DBPCFC中,未发生严重反应,也无需使用肾上腺素。
这是第一项对一系列有食物过敏反应病史且饮食史中无食物过敏已消退迹象的儿童连续进行DBPCFC的研究。我们的研究表明,对于此类儿童,即使饮食史中无过敏反应已消退的迹象,但当特异性IgE水平低于其他研究报道的预测激发试验阳性结果的既定临界值时,也应考虑通过DBPCFC重新评估对食物的临床反应性。尽管存在严重反应的潜在风险,但在这些儿童中进行DBPCFC是安全的。